Non invasive evaluation of nonalcoholic steatohepatitis (NASH)

Authors

  • Farahnaz Joukar
  • Mehrnaz Asgharnezhad
  • Noufar Kiyani
  • Fariborz Mansour-Ghanaei
  • Masrour Vahhabi-Moghaddam
Abstract:

This article doesn't have abstract

Upgrade to premium to download articles

Sign up to access the full text

Already have an account?login

similar resources

Noninvasive evaluation of nonalcoholic steatohepatitis (NASH).

Sir Non-alcoholic fatty liver disease (NAFLD) encompasses a wide spectrum of conditions, ranging from a simple fatty liver to non-alcoholic steatohepatitis (NASH) with or without fibrosis, to cirrhosis and its complications (1). It is important to distinguish NASH from simple fatty liver because NASH patients are in greater risk of developing cirrhosis, liver failure and hepatocellular carcinom...

full text

Nonalcoholic Steatohepatitis (NASH) — Symptoms and Treatment

Non-alcoholic steatohepatitis, one form of the non-alcoholic fatty liver disease spectrum, has been associated with obesity and lipid dysregulation. The patient usually presents with abnormal lipid and liver profiles. The most evidence based treatment for non-alcoholic steatohepatitis involves around weight loss, glycemic control and avoiding liver insulting drugs. Our current understanding of ...

full text

Nonalcoholic Steatohepatitis (NASH) — Symptoms and Treatment

Non-alcoholic steatohepatitis, one form of the non-alcoholic fatty liver disease spectrum, has been associated with obesity and lipid dysregulation. The patient usually presents with abnormal lipid and liver profiles. The most evidence based treatment for non-alcoholic steatohepatitis involves around weight loss, glycemic control and avoiding liver insulting drugs. Our current understanding of ...

full text

Nonalcoholic Steatohepatitis (NASH) — Symptoms and Treatment

Non-alcoholic steatohepatitis, one form of the non-alcoholic fatty liver disease spectrum, has been associated with obesity and lipid dysregulation. The patient usually presents with abnormal lipid and liver profiles. The most evidence based treatment for non-alcoholic steatohepatitis involves around weight loss, glycemic control and avoiding liver insulting drugs. Our current understanding of ...

full text

Profiles of Nonalcoholic Steatohepatitis (NASH) Patients in Indonesia

Aim: to know the clinical picture of subjects with NASH in Jakarta, Indonesia and the prevalence of insulin resistance, TNF-α, and adiponectin levels among them. Methods: this was a comparative cross-sectional study between patients with histopathologically confirmed NASH and normal subjects. The population of study was patients with fatty liver without history or significant consumption of eth...

full text

My Resources

Save resource for easier access later

Save to my library Already added to my library

{@ msg_add @}


Journal title

volume 4  issue None

pages  797- 798

publication date 2013-01

By following a journal you will be notified via email when a new issue of this journal is published.

Keywords

Hosted on Doprax cloud platform doprax.com

copyright © 2015-2023